AstraZeneca invests over $100 million in global youth health program
The pharmaceutical company AstraZeneca has announced a major investment in its "Young Health Programme." The company plans to invest over $100 million in the project, with the program continuing its operations until 2030.
The main goal of this initiative is to support young people around the world in managing their health. The program focuses on the prevention of non-communicable diseases, such as diabetes, cancer, and cardiovascular and respiratory issues, which are becoming increasingly common among adolescents.
The investment will be directed toward educational campaigns and projects that promote a healthy lifestyle. Through these funds, the company aims to inform young people about the risks of harmful habits and provide them with better access to health information.
This initiative is also significant for Bulgaria, as AstraZeneca is one of the key healthcare partners in the country. Such global programs often influence local health policies and support the development of preventive measures for society.
By extending the program until 2030, the company reaffirms its commitment to sustainable development and the care of future generations. The project is expected to reach millions of young people, helping them build a healthier future.